NCT04543370View on ClinicalTrials.gov

Study of Edasalonexent With Midazolam and Deflazacort in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

August 8, 2020

Primary Completion Date

September 6, 2020

Study Completion Date

October 1, 2020

Conditions
Healthy
Interventions
DRUG

Edasalonexent 2000 mg TID

CAT-1004 capsules

DRUG

Midazolam 2 MG/ML

2 mg/ml syrup

DRUG

Deflazacort 36Mg Tab

36 mg tablets

Trial Locations (1)

85283

Celerion Clinical Research Unit, Tempe

Sponsors
All Listed Sponsors
lead

Catabasis Pharmaceuticals

INDUSTRY

NCT04543370 - Study of Edasalonexent With Midazolam and Deflazacort in Healthy Subjects | Biotech Hunter | Biotech Hunter